Physician
Alabd Alrazzak, Baraa
Alabd Alrazzak, Baraa was paid $647K by Medicaid between Jan 2020 and Jul 2024, across 24 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.
33Billing provider infoALABD ALRAZZAK, BARAA
CYPRESS, TX 77433
CYPRESS, TX 77433
33aNPI1922312230assigned 07/28/2010
33bProvider typePediatrics Physician
28Total paid$647K
24GClaims9,773
24DCodes billed24
24AFirst – last monthJan 2020 – Jul 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#451 of 1,136
Median peer was paid$329K
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 299 | $18K | |
| 2021 | 1,662 | $100K | |
| 2022 | 2,300 | $151K | |
| 2023 | 3,086 | $251K | |
| 2024incomplete | 2,426 | $127K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 5,648 | 4,924 | $265K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 24% | 1,957 | 1,903 | $153K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 13% | 48 | 36 | $82K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 6.7% | 580 | 495 | $43K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 6.0% | 480 | 469 | $39K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.5% | 48 | 48 | $10K |
| 99205 | Prolong outpt/office vis | 1.3% | 83 | 77 | $8K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.3% | 63 | 63 | $8K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.3% | 129 | 116 | $8K |
| 96415 | 1.2% | 49 | 37 | $8K | |
| 88312 | <1% | 46 | 46 | $6K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 49 | 37 | $5K |
12 more codes
| 88313 | <1% | 46 | $4K | |
| 91065 | <1% | 12 | $2K | |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | <1% | 48 | $1K |
| 83013 | <1% | 70 | $1K | |
| 99441 | <1% | 48 | $1K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 25 | $896.93 |
| 83014 | <1% | 70 | $150.29 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 64 | $29.00 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 84 | $1.28 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 67 | $0.12 |
| C9285 | Lidocaine 70 mg/tetracaine 70 mg, per patch | 0% | 38 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.